Ms. Benczkowski, I was reading through some of your testimony. You were in front of this committee in 2011 and said:
Over the past 30 years, many drugs have been studied as possible treatments for Alzheimer’s disease, but few have reached the market and have only been marginally successful in treating mild symptoms.
I believe you mentioned something similar today. So is there a feeling now that when the CETA is implemented it will open the door to more innovative research on this disease and more drugs actually reaching their intended market?